Lubov Timchenko - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lubov Timchenko

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Plos One|April 15, 2020

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trialAdam Kurkiewicz, Anneli Cooper, Emily McIlwaine, et al.

Journal of Medicinal Chemistry|May 27, 2017

Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic DiseasesValle Palomo, Daniel I Perez, Carlos Roca, et al.

Hepatology Communications|August 24, 2022

β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinomaRuhi Gulati, Michael Johnston, Maria Rivas, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Plos One|April 15, 2020

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trialAdam Kurkiewicz, Anneli Cooper, Emily McIlwaine, et al.

Journal of Medicinal Chemistry|May 27, 2017

Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic DiseasesValle Palomo, Daniel I Perez, Carlos Roca, et al.

Hepatology Communications|August 24, 2022

β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinomaRuhi Gulati, Michael Johnston, Maria Rivas, et al.

Pageof 5